Outcome of COVID-19 infection in cancer patients during active systemic anticancer treatment. Single-institution experience. A retrospective analysis

INTRODUCTION: Patients with cancer undergoing active systemic anticancer treatment (chemotherapy, immunotherapy, targeted, or combination therapy) are at greater risk of COVID-19 infection than persons without cancer. In this paper, the authors analyse the spread of the coronavirus among cancer pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowara, Elżbieta, Działach, Eliza, Grajek, Mateusz, Kolosza, Zofia, Huszno, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547185/
https://www.ncbi.nlm.nih.gov/pubmed/34729033
http://dx.doi.org/10.5114/wo.2021.109362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547185/
https://www.ncbi.nlm.nih.gov/pubmed/34729033
http://dx.doi.org/10.5114/wo.2021.109362

Ejemplares similares